Acadian Asset Management’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,839
Closed -$46K 2166
2024
Q3
$46K Sell
41,839
-30,271
-42% -$33.3K ﹤0.01% 1819
2024
Q2
$149K Sell
72,110
-44,166
-38% -$91.3K ﹤0.01% 1482
2024
Q1
$237K Sell
116,276
-20,700
-15% -$42.2K ﹤0.01% 1161
2023
Q4
$292K Sell
136,976
-7,731
-5% -$16.5K ﹤0.01% 1153
2023
Q3
$526K Sell
144,707
-884
-0.6% -$3.21K ﹤0.01% 993
2023
Q2
$701K Sell
145,591
-2,920
-2% -$14.1K ﹤0.01% 973
2023
Q1
$696K Sell
148,511
-1,731
-1% -$8.11K ﹤0.01% 971
2022
Q4
$741K Sell
150,242
-1,800
-1% -$8.88K ﹤0.01% 925
2022
Q3
$811K Hold
152,042
﹤0.01% 854
2022
Q2
$931K Sell
152,042
-11,050
-7% -$67.7K ﹤0.01% 837
2022
Q1
$862K Sell
163,092
-5,613
-3% -$29.7K ﹤0.01% 865
2021
Q4
$1.2M Sell
168,705
-2,369
-1% -$16.9K ﹤0.01% 788
2021
Q3
$1.84M Buy
171,074
+3,434
+2% +$37K 0.01% 703
2021
Q2
$2.46M Buy
167,640
+16,981
+11% +$250K 0.01% 650
2021
Q1
$2.83M Buy
150,659
+25,771
+21% +$485K 0.01% 635
2020
Q4
$2.38M Buy
124,888
+21,865
+21% +$417K 0.01% 712
2020
Q3
$1.04M Buy
103,023
+68,818
+201% +$695K ﹤0.01% 901
2020
Q2
$373K Buy
+34,205
New +$373K ﹤0.01% 1295
2018
Q4
Sell
-1,163
Closed -$23K 1836
2018
Q3
$23K Hold
1,163
﹤0.01% 1498
2018
Q2
$29K Buy
+1,163
New +$29K ﹤0.01% 1493
2017
Q2
Sell
-9,582
Closed -$286K 1589
2017
Q1
$286K Buy
+9,582
New +$286K ﹤0.01% 986
2014
Q4
Sell
-1,533
Closed -$140K 1329
2014
Q3
$140K Sell
1,533
-9,250
-86% -$845K ﹤0.01% 802
2014
Q2
$1.24M Sell
10,783
-15,796
-59% -$1.82M 0.01% 567
2014
Q1
$3.22M Sell
26,579
-26,716
-50% -$3.24M 0.02% 397
2013
Q4
$6.7M Sell
53,295
-24,274
-31% -$3.05M 0.04% 302
2013
Q3
$8.44M Sell
77,569
-13,870
-15% -$1.51M 0.05% 250
2013
Q2
$7.7M Buy
+91,439
New +$7.7M 0.05% 240